Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 103.76% this year. Over the last six months, there has been a weaker performance of 142.40%. The price of DYN fallen by 12.87% during the last 30 days period. For the last 5-days stocks have improved 4.75%.
Dyne Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $30.27 on 03/01/24 and a low of $6.40 for the same time frame on 10/30/23.
52-week price history of DYN Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Dyne Therapeutics Inc’s current trading price is -10.47% away from its 52-week high, while its distance from the 52-week low is 323.44%. The stock’s price range during this time has been between $6.40 and $30.27. The trading volume for the Healthcare sector company’s shares reached about 1.37 million for the day, which was lower than the average daily volume of 2.08 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dyne Therapeutics Inc (DYN) has experienced a quarterly rise of 142.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.20B and boasts a workforce of 141 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.62, with a change in price of +19.38. Similarly, Dyne Therapeutics Inc recorded 1,542,062 in trading volume during the last 100 days, posting a change of +251.04%.
DYN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DYN stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.25.
DYN Stock Stochastic Average
Today’s raw stochastic average for Dyne Therapeutics Inc over the last 50 days is 82.34%.This indicates a increase from the raw stochastic average of the past 20 days, which was 63.02%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 49.44% and 49.83%, respectively.
